perfluorodecalin has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Chen, J; Chen, Y; Nie, F; Qin, W; Shi, Y; Su, D; Wang, H; Wang, S | 1 |
| Farah, ME; Ferreira, M; Hagedorn, N; Maia, M; Moraes-Filho, MN; Novais, E; Penha, FM; Portella, R; Rodrigues, EB; Shiroma, H | 1 |
| Bezinover, D; Brucklacher, R; Freeman, W; Janicki, PK; Kadry, Z; Mahmoud, S; Mani, H; Mets, B; Postula, M; Ramamoorthy, S; Spiess, B; Uemura, T; Weller, G | 1 |
| Choi, EJ; Jang, MH; Kie, JH; Kim, HR; Kim, JH; Lee, YK; Seoh, JY | 1 |
| Kishi, S; Kuroda, Y; Shinzeki, M; Takeyama, Y; Ueda, T; Yasuda, T | 1 |
| Jung, BO; Kim, DS; Kim, WD; Kim, WS; Koh, Y; Lee, SD; Lim, CM | 1 |
| Chung, MP; Han, J; Kim, H; Kim, HC; Kwon, OJ; Park, JW; Park, SJ; Rhee, CH; Suh, GY | 1 |
| Berkos, MV; Dolgushina, AD; Kochetygov, NI; Piatovskaia, NN; Sedova, LA | 1 |
9 other study(ies) available for perfluorodecalin and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Early high volume lung lavage for acute severe smoke inhalation injury in dogs.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Carboxyhemoglobin; Disease Models, Animal; Dogs; Fluorocarbons; Free Radicals; Hemodynamics; Male; Oxygen; Pulmonary Gas Exchange; Saline Solution, Hypertonic; Smoke Inhalation Injury; Time Factors | 2014 |
Development and initial experience with a colored perfluorocarbon liquid for intraocular tamponade in vitreoretinal surgery.
Topics: Adult; Aged; Animals; Anthraquinones; Cell Proliferation; Coloring Agents; Disease Models, Animal; Endotamponade; Female; Fibroblasts; Fluorocarbons; Humans; Male; Mice; Middle Aged; Pilot Projects; Prospective Studies; Retinal Detachment; Swine; Vitreoretinal Surgery; Vitreoretinopathy, Proliferative | 2014 |
Effect of cold perfusion and perfluorocarbons on liver graft ischemia in a donation after cardiac death model.
Topics: Adenosine Triphosphate; Animals; Caspase 3; Cold Ischemia; Disease Models, Animal; Fluorocarbons; Liver Diseases; Liver Transplantation; Myocardial Ischemia; Perfusion; Random Allocation; Rats; Real-Time Polymerase Chain Reaction; Tissue Preservation | 2014 |
Hyperoxygenation attenuated a murine model of atopic dermatitis through raising skin level of ROS.
Topics: Animals; Dermatitis, Atopic; Dinitrochlorobenzene; Disease Models, Animal; Fluorocarbons; Hyperbaric Oxygenation; Indoleamine-Pyrrole 2,3,-Dioxygenase; Male; Mice; Mice, Inbred BALB C; Oxygen; Pyroglyphidae; Reactive Oxygen Species; Skin | 2014 |
Intraperitoneal administration of oxygenated perfluorochemical inhibits bacterial translocation associated with severe acute pancreatitis.
Topics: Animals; Bacterial Translocation; Deoxycholic Acid; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fluorocarbons; In Situ Nick-End Labeling; Injections, Intraperitoneal; Male; Pancreatitis, Acute Necrotizing; Probability; Random Allocation; Rats; Rats, Wistar; Reference Values; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric | 2003 |
An optimal dose of perfluorocarbon for respiratory mechanics in partial liquid ventilation for dependent lung-dominant acute lung injury.
Topics: Animals; Bronchoalveolar Lavage; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorocarbons; Functional Residual Capacity; Instillation, Drug; Plasma Substitutes; Positive-Pressure Respiration; Pulmonary Gas Exchange; Rabbits; Respiratory Distress Syndrome; Respiratory Mechanics; Trachea; Treatment Outcome | 2000 |
Partial liquid ventilation with perfluorocarbon improves gas exchange and decreases inflammatory response in oleic acid-induced lung injury in beagles.
Topics: Animals; Blood Cell Count; Bronchoalveolar Lavage Fluid; Carbon Dioxide; Disease Models, Animal; Dogs; Female; Fluorocarbons; Hemodynamics; Histocytochemistry; Inflammation; Lung Diseases; Male; Oleic Acid; Oxygen; Pulmonary Gas Exchange; Pulmonary Ventilation; Respiratory Function Tests; Ventilators, Mechanical | 1999 |
[Activation of the complement system of plasma and the changes in various parameters of homeostasis in rats after intravenous administration of emulsion of organoperfluorine compounds].
Topics: Animals; Complement Activation; Disease Models, Animal; Emulsions; Fluorocarbons; Hemodynamics; Hypotension; Hypoxia; In Vitro Techniques; Injections, Intravenous; Oxygen Consumption; Rats | 1990 |